|
|
Flinders Academic Commons >
Browsing by Author Feit, Frederick
Showing results 1 to 5 of 5
| Preview | Issue Date | Title | Author(s) | | 2003 | Bivalirudin provides increasing benefit with
decreasing renal function: a meta-analysis of randomized trials | Chew, Derek Peng; Bittl, John A; Lincoff, A Michael; Henry, Tim; Feit, Frederick; Bhatt, Deepak L; Berger, P; Mccullough, P A; Kimball, W |
| 2005 | Bivalirudin versus heparin and glycoprotein
IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous
coronary intervention (A subanalysis of the REPLACE-2 trial) | Chew, Derek Peng; Lincoff, A Michael; Gurm, Hitinder; Wolski, Katherine; Cohen, David J; Henry, Tim; Feit, Frederick; Topol, Eric J |
| 2004 | Comparison of Bivalirudin versus heparin during
percutaneous coronary intervention (the randomized evaluation of PCI linking angiomax to
reduced clinical events [REPLACE]-1 trial) | Lincoff, A Michael; Bittl, John A; Kleiman, Neal S; Sarembock, Ian J; Jackman, J Daniel; Mehta, Sameer; Tannenbaum, Mark A; Niederman, Alan L; Bachinsky, William B; Tift-Mann, J; Parker, H Graham; Kereiakes, Dean J; Harrington, Robert A; Feit, Frederick; Maierson, Elizabeth S; Chew, Derek Peng; Topol, Eric J |
| 2007 | Predictors and impact of major hemorrhage on
mortality following percutaneous coronary intervention from the REPLACE-2
Trial | Bittl, John A; Chew, Derek Peng; Feit, Frederick; Voeltz, Michele D; Attubato, Michael J; Lincoff, A Michael; Topol, Eric J; Manoukian, Steven V |
| 2008 | Safety and efficacy of switching from either
unfractionated Heparin or Enoxaparin to Bivalirudin in patients with Non-ST-Segment
elevation acute coronary syndromes managed with an invasive strategy. Results from the
ACUITY trial | White, Harvey D; Chew, Derek Peng; Hoekstra, James; Miller, Chadwick D; Pollack, Charles V; Feit, Frederick; Lincoff, A Michael; Bertrand, Michel E; Pocock, Stuart J; Ware, James H; Ohman, E Magnus; Mehran, Roxana; Stone, G W |
Showing results 1 to 5 of 5
|
